Big Oil, Big Pharma, Big Tech: Is Big Grocery Next?
A Kroger-Albertsons merger would create a supermarket behemoth. But the grocery giant would still be No. 2 in the U.S. market, trailing Walmart.
A Kroger-Albertsons merger would create a supermarket behemoth. But the grocery giant would still be No. 2 in the U.S. market, trailing Walmart.
“Meat” that’s fermented, made from plants or cultivated in the lab is only beginning to find a place on America’s menu
How does your broker’s trading app compare?
What it takes to run a profitable channel
A quick look at the platform’s most
popular content
The new reality will favor those able and willing to collaborate effectively with AI AI is here. How soon it transforms the economy depends on how fast the technology advances. But experts agree the transition to the “jobs of tomorrow” is already underway. In late 2022, ChatGPT, an AI chatbot developed by San Francisco-based OpenAI, … Continued
Four experts weigh in on the state of generative AI and the impact of ChatGPT. Just to be fair, we also asked the chatbot for its opinions. Luckbox: On a scale where “1” stands for pocket calculators and “100” is Skynet—the superintelligent group mind that rules the future in the Terminator movies—what’s the current state … Continued
Cost Plus Drugs Company is selling prescription medications at dramatically low prices What would happen if drug pricing made sense to consumers? Mark Cuban Cost Plus Drug Company, which launched its online pharmacy about a year ago, is trying to answer that question. Its approach is easy to understand—even if it’s difficult to implement. First, … Continued
A shortage began with Adderall and spread to Ritalin. A government crackdown made it worse. As 2023 began, the national Adderall shortage had spread to other drugs used to treat attention-deficit/hyperactivity disorder (ADHD). Experts expect the mess to continue for much of the year. The shortages started with Adderall—known generically as amphetamine mixed salts—which … Continued
Mark Cuban, the nation’s newest retail drug impresario, joins our expert panel to weigh in on the state of American pharma. Here’s what our panelists say lies ahead. (Luckbox lightly edited the responses for brevity and clarity.) luckbox: Only 25% of Americans view of the pharmaceutical industry favorably. What’s the biggest problem? Posner: It’s remarkable … Continued